Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor revision note updated from v3.4.1 to v3.4.2; no user-facing content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded Sarah Cannon Research Institute / Tennessee Oncology in Nashville, TN as a recruitment site; total study locations updated from 127 to 128.SummaryDifference0.2%

- Check26 days agoChange DetectedNo significant additions or deletions were detected; the page content and structure appear unchanged between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedUI updates add a Show/Hide glossary control and No FEAR Act data capitalization tweaks, along with Last Update fields and a new Revision: v3.4.0. These changes do not affect core study details or results.SummaryDifference0.2%

- Check40 days agoChange DetectedThe site now shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedStudy Record Dates now displays 'Last Update Posted (Estimated)' instead of 'Last Update Posted'; the underlying timestamp data are unchanged.SummaryDifference0.0%

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.